Form 8-K - Current report:
SEC Accession No. 0001213900-20-018871
Filing Date
2020-07-28
Accepted
2020-07-28 16:07:46
Documents
2
Period of Report
2020-07-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea124640-8k_inmunebioinc.htm 8-K 16294
2 INMUNE BIO, INC. FEATURED ON FOX NEWS (VIDEO): STNF AND CYTOKINE STORM ea124640ex99-1_inmunebioinc.htm EX-99.1 5960
  Complete submission text file 0001213900-20-018871.txt   23368
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 201053960
SIC: 2836 Biological Products, (No Diagnostic Substances)